Athersys Announces Meeting With FDA to Discuss Advancing Clinical Development ...
MarketWatch (press release)
CLEVELAND, Apr 27, 2012 (GlobeNewswire via COMTEX) -- Athersys, Inc. (UTD:ATHX) announced today that a scheduled meeting with the FDA was held to discuss the results of its recently completed clinical trial involving the administration of MultiStem to ...

and more »


More...